152 related articles for article (PubMed ID: 5311056)
1. Therapy of leprosy.
Convit J; Browne SG; Languillon J; Pettit JH; Ramanujam K; Sagher F; Sheskin J; Tarabini G; de Souza Lima L; Tolentino JG; Waters MF; Bechelli LM; MartÃnez DomÃnguez V
Bull World Health Organ; 1970; 42(5):667-72. PubMed ID: 5311056
[TBL] [Abstract][Full Text] [Related]
2. Clofazimine (B663, Geigy) in leprosy reactions.
Smith RB
Australas J Dermatol; 1972 Apr; 13(1):31-5. PubMed ID: 5082494
[No Abstract] [Full Text] [Related]
3. Chemotherapy of leprosy.
Leiker DL
Int J Lepr Other Mycobact Dis; 1971; 39(2):462-6. PubMed ID: 4948084
[No Abstract] [Full Text] [Related]
4. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472
[No Abstract] [Full Text] [Related]
5. [Early diagnosis, therapy, and research in the control of leprosy].
Contreras Duenas F
Offentl Gesundheitswes; 1970 Dec; 32(12):667-71. PubMed ID: 4250373
[No Abstract] [Full Text] [Related]
6. [Lampren in the treatment of leprosy].
Ahrens T
Schweiz Rundsch Med Prax; 1970 Mar; 59(11):387-9. PubMed ID: 5519711
[No Abstract] [Full Text] [Related]
7. The treatment of leprosy and its acute complications.
Jopling WH
Trop Doct; 1973 Jan; 3(1):8-11. PubMed ID: 4120944
[No Abstract] [Full Text] [Related]
8. The evaluation of present antileprosy compounds.
Browne SG
Adv Pharmacol (1962); 1969; 7():211-51. PubMed ID: 4190238
[No Abstract] [Full Text] [Related]
9. The evaluation of present antileprosy compounds.
Browne SG
Adv Pharmacol Chemother; 1969; 7():211-51. PubMed ID: 4910168
[No Abstract] [Full Text] [Related]
10. [Trial of a new leprostatics (B-663) in the treatment of lepromatous leprosy].
Renders A
Ann Soc Belges Med Trop Parasitol Mycol; 1968; 48(6):625-35. PubMed ID: 5759964
[No Abstract] [Full Text] [Related]
11. Management of neuritis in leprosy.
Pfaltzgraff RE
Trop Doct; 1973 Jul; 3(3):138-9. PubMed ID: 4715065
[No Abstract] [Full Text] [Related]
12. Antileprosy drugs.
Br Med J; 1971 Jul; 3(5767):174-6. PubMed ID: 4104273
[No Abstract] [Full Text] [Related]
13. Treatment of leprosy with Lampren (B.663 Geigy).
De las Aguas JT
Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089
[No Abstract] [Full Text] [Related]
14. The drug treatment of leprosy.
Browne SG
Practitioner; 1975 Oct; 215(1288):493-500. PubMed ID: 1202470
[No Abstract] [Full Text] [Related]
15. A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosy.
Freerksen E; Rosenfeld M
Arzneimittelforschung; 1972 Aug; 22(8):1235-42. PubMed ID: 4678384
[No Abstract] [Full Text] [Related]
16. A survey of the drugs with activity against M. leprae in mice.
Shepard CC
Int J Lepr Other Mycobact Dis; 1971; 39(2):340-8. PubMed ID: 4948080
[No Abstract] [Full Text] [Related]
17. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
Tolentino JG; Rodriquez JN; Abalos RM
Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
[No Abstract] [Full Text] [Related]
18. Treatment of steroid dependant cases of recurrent lepra reaction with a combination of thalidomide and clofazimine.
Ramu G; Girdhar A
Lepr India; 1979 Oct; 51(4):497-504. PubMed ID: 522443
[TBL] [Abstract][Full Text] [Related]
19. An open trial with clofazimine in the management of recurrent lepra reaction using thalidomide as a control drug.
Iyer CG; Ramu G
Lepr India; 1976 Oct; 48(4 Suppl):690-4. PubMed ID: 1026805
[No Abstract] [Full Text] [Related]
20. Thalidomide in leprosy--study of 94 cases.
Parikh DA; Ganapati R; Revankar CR
Indian J Lepr; 1986; 58(4):560-6. PubMed ID: 3572098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]